Reducing alcohol use among people with TB and HIV in India
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
This study is looking at how drinking too much alcohol affects people in India who are being treated for both tuberculosis (TB) and HIV, and it will test a friendly program to help them cut back on drinking so they can stick to their treatment better and feel healthier.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10871707 on NIH RePORTER |
What this research studies
This research investigates the impact of unhealthy alcohol use on tuberculosis (TB) and HIV treatment outcomes in India, where the incidence of TB is notably high. It aims to implement a culturally relevant intervention called Counseling on Alcohol Problems (CAP), which combines Cognitive Behavioral Therapy and Motivational Enhancement Therapy, to help patients reduce their alcohol consumption. The study will evaluate the effectiveness of this intervention in improving treatment adherence and health outcomes for individuals living with both TB and HIV. By addressing alcohol use, the research seeks to enhance the overall management of these co-occurring conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with both tuberculosis and HIV in India who engage in unhealthy alcohol consumption.
Not a fit: Patients who do not have TB or HIV, or those who do not consume alcohol, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment adherence and health outcomes for patients with TB and HIV who struggle with alcohol use.
How similar studies have performed: Previous research has shown that interventions targeting alcohol use can improve health outcomes in patients with TB and HIV, indicating a promising approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Gupta, Amita — Johns Hopkins University
- Study coordinator: Gupta, Amita
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.